Yeghiazarians, Yerem <br/><br/>
Myocardial improvement with human embryonic stem cell-derived cardiomyocytes enriched by p38MAPK inhibition.  [electronic resource] 

 -  Cytotherapy  Feb 2012 
 - 223-31 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1477-2566 
<br/><br/><label>Standard No.: </label>10.3109/14653249.2011.623690  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis<br/>Cell Differentiation<br/>Disease Models, Animal<br/>Embryonic Stem Cells--cytology<br/>Enzyme Activation--drug effects<br/>Fibroblasts--cytology<br/>Heart Ventricles--physiopathology<br/>Humans<br/>Imidazoles--pharmacology<br/>Immunohistochemistry<br/>Injections--methods<br/>Mice<br/>Mice, SCID<br/>Mitogen-Activated Protein Kinase 14--antagonists & inhibitors<br/>Myocardial Infarction--therapy<br/>Myocytes, Cardiac--cytology<br/>Pyridines--pharmacology<br/>Teratoma--metabolism